| 王玥,凌芳,赵明芬.中医药调节肠道菌群防治冠心病的研究概述[J].安徽医药,2024,28(4):643-647. |
| 中医药调节肠道菌群防治冠心病的研究概述 |
| Overview of research on the prevention and treatment of coronary heart disease by regulating intestinal flora with traditional Chinese medicine |
| |
| DOI：10.3969/j.issn.1009-6469.2024.04.002 |
| 中文关键词: 冠心病 肠道菌群 中医药 综述 |
| 英文关键词: Coronary heart disease Gut mircrobiota Chinese medicine Review |
| 基金项目:新疆维吾尔自治区自然科学基金面上项目( 2021D01C227)；省部共建中亚高发病成因与防治国家重点实验室( SKL-HIDCA-2020-ZY3) |
|
| 摘要点击次数: 343 |
| 全文下载次数: 142 |
| 中文摘要: |
| 冠状动脉粥样硬化性心脏病(CHD)病程较长，发病机制是多种因素相互作用引发，肠道菌群( GM)的结构紊乱及功能障碍与 CHD的进展密切相关。此外， GM的代谢物也可影响 CHD的发展和预后。现基于中医学基础理论，探讨 GM及代谢物质与 CHD之间的关系，进一步论述中医药防治 CHD的现代研究进展。 |
| 英文摘要: |
| Coronary heart disease (CHD) has a long course and its pathogenesis is caused by the interaction of multiple factors. Thestructural disorder and dysfunction of gut microbiota (GM) are closely related to the progression of CHD. In addition, the metabolites ofGM can also affect the development and prognosis of CHD. Based on the basic theories of traditional Chinese medicine, this paper ex?plores the relationship between gut microbiota and metabolites and coronary heart disease, and further discusses the modern research progress of traditional Chinese medicine in the prevention and treatment of coronary heart disease. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
